A study shows that helium ions can be more precisely delivered to tumours than protons or carbon ions, which are presently the only beams licensed for treatment, with a biological effectiveness between the two. The accelerator required for helium is considerably smaller than a standard carbon ion synchrotron. To exploit the potential of helium therapy and of other emerging particle therapy techniques, in the framework of the Next Ion Medical Machine Study (NIMMS) at CERN, the design of a compact synchrotron optimised for acceleration of proton and helium beams has been investigated.
top of page
Search
Recent Posts
See AllRaySearch Laboratories, medical technology company, and partner QST (National Institutes for Quantum Science and Technology) in Chiba, Japan, have taken a significant step forward with QST's acquisiti
An article by the Edelgas Group delves into the importance of helium in national defence, notably in the development of advanced drones and laser systems. This is particularly pertinent this week foll
Koya Capital has signed a partnership agreement to work with Stratek Global, a reactor manufacturer, to secure financing and construction of a ZAR 9bn (US$480mm) first-of-a-kind reactor in South Afric
bottom of page